One exception was a study of South Korean men with initial prostate-specific antigen (PSA) levels ranging from 4 to 10 ng ml−1 who underwent TRUS-guided prostate biopsy–patients with a history of prostatitis were excluded and the investigators subsequently found NLR was significantly associated with prostate cancer detection [64]. This evidence concerns the gene KLK3 and prostate carcinoma.